Related Experiment Videos

Vitiligo: where do we stand?

J P Ortonne1, S K Bose

  • 1Service de Dermatologie, Hopital Pasteur, Nice, France.

Pigment Cell Research
|March 1, 1993
PubMed

Insights

Vitiligo, a common skin disorder affecting 1-4% of the population, involves melanocyte loss through unknown mechanisms. Current research explores immune, neural, and self-destruct hypotheses, alongside new theories on growth factors and cellular defects.

Area of Science:

  • Dermatology
  • Cell Biology
  • Immunology

Background:

  • Vitiligo is a common skin disorder affecting 1-4% of the global population.
  • Characterized by melanocyte loss in epidermis and hair follicles.
  • Pathogenesis remains largely unknown, posing challenges for dermatologists and researchers.

Purpose of the Study:

  • To review current understanding of vitiligo pathogenesis.
  • To explore prevailing and emerging hypotheses.
  • To highlight the importance of melanocyte research.

Main Methods:

  • Review of existing literature on vitiligo.
  • Analysis of cellular and molecular mechanisms.
  • Discussion of various pathogenetic theories.

Main Results:

  • Vitiligo involves not only melanocytes but also keratinocytes and Langerhans cells.
  • Extracutaneous involvement of the melanocyte system is increasingly recognized.
  • Multiple hypotheses exist, including immune, neural, self-destruct, growth factor deficiency, endoplasmic reticulum defects, melatonin receptor abnormalities, and free radical damage.

Conclusions:

  • The exact cause of melanocyte loss in vitiligo is undetermined.
  • It is likely that multiple pathogenetic mechanisms contribute to vitiligo.
  • Further research is needed to elucidate the complex etiology of vitiligo.

Related Concept Videos